de Jong EMGJ - Search Results

1

Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial.

Puig L, Costanzo A, de Jong EMGJ, Torres T, Warren RB, Wapenaar R, Wegner S, Gorecki P, Gramiccia T, Jazra M, Buyze J, Conrad C. Puig L, et al. Among authors: de jong emgj. Am J Clin Dermatol. 2024 Mar;25(2):315-325. doi: 10.1007/s40257-023-00816-1. Epub 2023 Oct 7. Am J Clin Dermatol. 2024. PMID: 37804472 Free PMC article.

2

Topical application of 13-cis-retinoic acid in the treatment of chronic plaque psoriasis.

Bischoff R, De Jong EM, Rulo HF, Sendagorta E, Czarnetzki BM, Van de Kerkhof PC. Bischoff R, et al. Clin Exp Dermatol. 1992 Jan;17(1):9-12. doi: 10.1111/j.1365-2230.1992.tb02523.x. Clin Exp Dermatol. 1992. PMID: 1424269 Clinical Trial.

3

A phase II multicenter clinical trial of systemic bexarotene in psoriasis.

Smit JV, Franssen ME, de Jong EM, Lambert J, Roseeuw DI, De Weert J, Yocum RC, Stevens VJ, van De Kerkhof PC. Smit JV, et al. J Am Acad Dermatol. 2004 Aug;51(2):249-56. doi: 10.1016/j.jaad.2002.08.001. J Am Acad Dermatol. 2004. PMID: 15280844 Clinical Trial.

4

Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin.

Smit JV, de Jong EM, van Hooijdonk CA, Otero ME, Boezeman JB, van de Kerkhof PC. Smit JV, et al. J Am Acad Dermatol. 2004 Aug;51(2):257-64. doi: 10.1016/j.jaad.2004.03.002. J Am Acad Dermatol. 2004. PMID: 15280845 Clinical Trial.

5

A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis.

Mrowietz U, de Jong EM, Kragballe K, Langley R, Nast A, Puig L, Reich K, Schmitt J, Warren RB. Mrowietz U, et al. J Eur Acad Dermatol Venereol. 2014 Apr;28(4):438-53. doi: 10.1111/jdv.12118. Epub 2013 Feb 26. J Eur Acad Dermatol Venereol. 2014. PMID: 23437792 Free article.

6

Barriers to the prescription of systemic therapies for moderate-to-severe psoriasis--a multinational cross-sectional study.

Nast A, Mrowietz U, Kragballe K, de Jong EM, Puig L, Reich K, Warren RB, Werner R, Kopkow C, Schmitt J. Nast A, et al. Arch Dermatol Res. 2013 Dec;305(10):899-907. doi: 10.1007/s00403-013-1372-3. Epub 2013 Jun 8. Arch Dermatol Res. 2013. PMID: 23748949

7

Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study.

Reich K, Zschocke I, Bachelez H, de Jong EM, Gisondi P, Puig L, Warren RB, Mrowietz U; TTOP study group. Reich K, et al. J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1156-63. doi: 10.1111/jdv.12774. Epub 2014 Oct 26. J Eur Acad Dermatol Venereol. 2015. PMID: 25346093 Free article. Clinical Trial.

8

Validation of the Simplified Psoriasis Index in Dutch children and adolescents with plaque psoriasis.

van Geel MJ, Otero ME, de Jong EM, van de Kerkhof PC, Seyger MM. van Geel MJ, et al. Br J Dermatol. 2017 Mar;176(3):771-776. doi: 10.1111/bjd.15120. Epub 2016 Dec 8. Br J Dermatol. 2017. PMID: 27718521

9

Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients.

Talamonti M, Galluzzo M, van den Reek JM, de Jong EM, Lambert JLW, Malagoli P, Bianchi L, Costanzo A. Talamonti M, et al. Br J Dermatol. 2017 Aug;177(2):489-496. doi: 10.1111/bjd.15387. Epub 2017 Jun 22. Br J Dermatol. 2017. PMID: 28207934

10

A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP).

Reich K, Zschocke I, Bachelez H, de Jong EMGJ, Gisondi P, Puig L, Warren RB, Ortland C, Mrowietz U; PSO-TOP study group. Reich K, et al. Among authors: de jong emgj. Br J Dermatol. 2017 Jul;177(1):197-205. doi: 10.1111/bjd.15466. Epub 2017 Jun 6. Br J Dermatol. 2017. PMID: 28301043 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

283 results

Search Page